Long Noncoding RNA LINC02582 Acts Downstream of Mir-200C to Promote Radioresistance Through CHK1 in Breast Cancer Cells.

Baiyao Wang,Jieling Zheng,Rong Li,Yunhong Tian,Jie Lin,Yingying Liang,Quanquan Sun,Anan Xu,Ronghui Zheng,Mengzhong Liu,Aimin Ji,Junguo Bu,Yawei Yuan
DOI: https://doi.org/10.1038/s41419-019-1996-0
2019-01-01
Cell Death and Disease
Abstract:Radiotherapy is essential to treat breast cancer and microRNA (miRNA) miR-200c is considered as a radiosensitizer of breast cancer. However, the molecular mechanisms by which miR-200c regulates radiosensitivity remain largely unknown. In the present study, we showed that induction of miR-200c led to widespread alteration in long noncoding RNA (lncRNA) expression in breast cancer cells. We identified lncRNA LINC02582 as a target of miR-200c. Inhibition of LINC02582 expression increased radiosensitvity, while overexpression of LINC02582 promoted radioresistance. Mechanistically, LINC02582 interacts with deubiquitinating enzyme ubiquitin specific peptidase 7 (USP7) to deubiquitinate and stabilize checkpoint kinase 1 (CHK1), a critical effector kinase in DNA damage response, thus promoting radioresistance. Furthermore, we detected an inverse correlation between the expression of miR-200c vs. LINC02582 and CHK1 in breast cancer samples. These findings identified LINC02582 as a downstream target of miR-200c linking miR-200c to CHK1, in which miR-200c increases radiosensitivity by downregulation of CHK1.
What problem does this paper attempt to address?